Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug 9:9:983583.
doi: 10.3389/fmed.2022.983583. eCollection 2022.

Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases

Keshav Raj Paudel  1 , Dinesh Kumar Chellappan  2 , Ronan MacLoughlin  3   4   5 , Terezinha de Jesus Andreoli Pinto  6 , Kamal Dua  7   8 , Philip M Hansbro  1
Affiliations
Editorial

Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases

Keshav Raj Paudel et al. Front Med (Lausanne). .
No abstract available

Keywords: chronic respiratory disease; drug delivery; drug discovery; pulmonary medicine; therapeutic delivery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Advanced therapeutic delivery for the management of chronic respiratory diseases

References

    1. Khursheed R, Paudel KR, Gulati M, Vishwas S, Jha NK, Hansbro PM, et al. . Expanding the arsenal against pulmonary diseases using surface-functionalized polymeric micelles: breakthroughs and bottlenecks. Nanomedicine (Lond). (2022). 10.2217/nnm-2021-0451. [Epub ahead of print]. - DOI - PubMed
    1. Tan CL, Chan Y, Candasamy M, Chellian J, Madheswaran T, Sakthivel LP, et al. . Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental models. Eur J Pharmacol. (2022) 919:174821. 10.1016/j.ejphar.2022.174821 - DOI - PubMed
    1. Paudel KR, Mehta M, Yin GHS, Yen LL, Malyla V, Patel VK, et al. . Berberine-loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Environ Sci Pollut Res Int. (2022) 29:46830–47. 10.21203/rs.3.rs-926601/v1 - DOI - PMC - PubMed
    1. Paudel KR, Panth N, Manandhar B, Singh SK, Gupta G, Wich PR, et al. . Attenuation of cigarette-smoke-induced oxidative stress, senescence, and inflammation by berberine-loaded liquid crystalline nanoparticles: in vitro study in 16HBE and RAW264.7 cells. Antioxidants (Basel). (2022) 11:873. 10.3390/antiox11050873 - DOI - PMC - PubMed
    1. Mehta M, Paudel KR, Shukla SD, Allam V, Kannaujiya VK, Panth N, et al. . Recent trends of NFkappaB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases. J Control Release. (2021) 337:629–44. 10.1016/j.jconrel.2021.08.010 - DOI - PubMed

Publication types

LinkOut - more resources